Oncolytics Biotech (ONCY) Exchange Rate Effect (2009 - 2025)
Oncolytics Biotech's (ONCY) quarterly Exchange Rate Effect came in at $122106.0 in Q4 2025, down 80.1% year-on-year from $613482.7 in Q4 2024, and down 48.45% on a QoQ basis from $236883.0 in Q3 2025.
Oncolytics Biotech (ONCY) Exchange Rate Effect (2009 - 2025) Analysis & Trends
Oncolytics Biotech (ONCY) has 17 years of Exchange Rate Effect data on file, last reported at $122106.0 in Q4 2025.
- On a quarterly basis, Exchange Rate Effect fell 80.1% year-over-year to $122106.0 in Q4 2025; TTM through Dec 2025 was $296112.8, a 74.55% decrease from a year earlier, with the FY2025 full-year figure at $121000.0, up 141.87% from the prior year.
- Exchange Rate Effect for Q4 2025 stood at $122106.0, down from $236883.0 in the prior quarter.
- Over the last five years, Exchange Rate Effect for ONCY reached as high as $1.4 million in Q3 2022 and fell as low as -$602028.0 in Q2 2021.
- Historically, Exchange Rate Effect has averaged $100149.7 across 5 years, with a median of $24333.4 in 2025.
- On a YoY basis, Exchange Rate Effect climbed as much as 4603.97% in 2021 and fell as far as 546.31% in 2021.
- Year by year, Exchange Rate Effect stood at -$288757.7 in 2021, then grew by 28.56% to -$206276.8 in 2022, then slumped by 143.57% to -$502422.3 in 2023, then surged by 222.1% to $613482.7 in 2024, then sank by 80.1% to $122106.0 in 2025.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were $122106.0 in Q4 2025, $236883.0 in Q3 2025, and -$417871.5 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Oncolytics Biotech | 372.40 Mn | 372.40 Mn | - | 122,106.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 122,106.00 |
| Dec 31, 2025 | 122,106.00 |
| Sep 30, 2025 | 236,883.01 |
| Sep 30, 2025 | 236,883.01 |
| Jun 30, 2025 | -417,871.54 |
| Jun 30, 2025 | -417,871.54 |
| Mar 31, 2025 | -21,604.41 |
| Mar 31, 2025 | -21,604.41 |
| Dec 31, 2024 | 613,482.71 |
| Dec 31, 2024 | 613,482.71 |
| Sep 30, 2024 | -157,606.48 |
| Sep 30, 2024 | -157,606.48 |
| Jun 30, 2024 | 179,860.57 |
| Jun 30, 2024 | 179,860.57 |
| Mar 31, 2024 | 527,642.49 |
| Mar 31, 2024 | 527,642.49 |
| Dec 31, 2023 | -502,422.30 |
| Dec 31, 2023 | -502,422.30 |
| Sep 30, 2023 | 325,225.68 |
| Sep 30, 2023 | 325,225.68 |